Загрузка...
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer
PURPOSE: Triple-negative breast cancer (TNBC) is highly malignant and has poor prognosis and a high mortality rate. The lack of effective therapy has spurred our investigation of new targets for treating this malignant cancer. Here, we identified RON (macrophage-stimulating 1 receptor) and MET (MET...
Сохранить в:
| Опубликовано в: : | Cancer Res Treat |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Cancer Association
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373856/ https://ncbi.nlm.nih.gov/pubmed/32324988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.726 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|